Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 11Terminated 4Active not recruiting 2Withdrawn 1Unknown 1Suspended 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4Sarcoma 3

Conditions

Squamous Cell Carcinoma of Head and Neck 15Head and Neck Neoplasms 10Prostatic Neoplasms 8Rectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Pancreatic Neoplasms 4Glioblastoma 4Urinary Bladder Neoplasms 3Sarcoma 3Oropharyngeal Neoplasms 3Lymphoma, Extranodal NK-T-Cell 3Kidney Neoplasms 3Gliosarcoma 3Brain Neoplasms 3Neoplasm Metastasis 2Mesothelioma, Malignant 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Glioma 2Congenital Abnormalities 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Carcinoma 2Astrocytoma 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Vomiting 1Uterine Cervical Neoplasms 1Stage IA Uterine Sarcoma 1Squamous Cell Carcinoma of Anal Canal 1

Interventions

Temozolomide 52Radiotherapy 24Bevacizumab 23Radiation 10Magnetic Resonance Spectroscopy 7Lomustine 7Carmustine 7Radiosurgery 6Surgical Procedures, Operative 5Irinotecan 5Radiotherapy, Intensity-Modulated 4Nivolumab 4Ipilimumab 4Erlotinib Hydrochloride 4Cilengitide 4Aminolevulinic Acid 4vocimagene amiretrorepvec 3vitespin 3sargramostim 3poly ICLC 3pembrolizumab 3fluoromisonidazole 3carmustine, poliferprosan 20 drug combination 3Vorinostat 3TPI-287 3O(6)-benzylguanine 3Granulocyte-Macrophage Colony-Stimulating Factor 3Flucytosine 3Dynamic Contrast Enhanced Magnetic Resonance Imaging 3Drug Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Glioblastoma × Radiotherapy, Intensity-Modulated × Clear all
NCT04397679 2025-01-15

Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma

Barbara Ann Karmanos Cancer Institute

Phase 1 Terminated
2 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT00669669 2022-05-18

O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas

Fred Hutchinson Cancer Center

Phase 1/2 Terminated
12 enrolled 13 charts
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT02039778 2017-06-05

STRONG

Beth Israel Medical Center

Phase NA Terminated
4 enrolled 8 charts
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

NCT02394665 2017-01-05

Dose Escalated MRSI Guided Radiation Therapy in Glioblastoma

University of Miami

Phase 2 Terminated
1 enrolled 3 charts
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡